Bladder cancer determination via two urinary metabolites: A biomarker pattern approach

Molecular and Cellular Proteomics

Volumn 10, Issue 10, 2011, Pages

  Huang, Zhenzhen ^a   Lin, Lin ^a   Gao, Yao ^a   Chen, Yongjing ^a   Yan, Xiaomei ^a   Xing, Jinchun ^b   Hang, Wei ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen First Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARNITINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROPHILICITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; URINALYSIS; BLADDER TUMOR; DISCRIMINANT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METABOLOME; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; URINE;

ADULT; AGED; CARNITINE; CHROMATOGRAPHY, LIQUID; DISCRIMINANT ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 80054050602     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.007922     Document Type: Article

References (41)

1. Mitra, A. P., and Cote, R. J. (2010) Molecular screening for bladder cancer: progress and potential. Nat. Rev. Urol. 7, 11-20
2. Pasikanti, K. K., Esuvaranathan, K., Ho, P. C., Mahendran, R., Kamaraj, R., Wu, Q. H., Chiong, E., and Chan, E. C. Y. (2010) Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer. J. Proteome Res. 9, 2988-2995
3. Chen, Y. T., Chen, C. L., Chen, H. W., Chung, T., Wu, C. C., Chen, C. D., Hsu, C. W., Chen, M. C., Tsui, K. H., Chang, P. L., Chang, Y. S., and Yu, J. S. (2010) Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology. J. Proteome Res. 9, 5803-5815
4. Cauberg, E. C., de Bruin, D. M., Faber, D. J., van Leeuwen, T. G., de la Rosette, J. J., and de Reijke, T. M. (2009) A New Generation of Optical Diagnostics for Bladder Cancer: Technology, Diagnostic Accuracy, and Future Applications. Eur. Urol. 56, 287-296
5. Schwamborn, K., Krieg, R. C., Grosse, J., Reulen, N., Weiskirchen, R., Knuechel, R., Jakse, G., and Henkel, C. (2009) Serum Proteomic Profiling in Patients with Bladder Cancer. Eur. Urol. 56, 989-996
6. Vrooman, O. P., and Witjes, J. A. (2008) Urinary Markers in Bladder Cancer. Eur. Urol. 53, 909-916
7. Feldman, A. S., Banyard, J., Wu, C. L., McDougal, W. S., and Zetter, B. R. (2009) Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Clin. Cancer Res. 15, 1024-1031
8. Schiffer, E., Vlahou, A., Petrolekas, A., Stravodimos, K., Tauber, R., Geschwend, J. E., Neuhaus, J., Stolzenburg, J. U., Conaway, M. R., Mischak, H., and Theodorescu, D. (2009) Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics. Clin. Cancer Res. 15, 4935-4943
9. Mitra, A. P., Bartsch, C. C., and Cote, R. J. (2009) Strategies for molecular expression profiling in bladder cancer. Cancer Metastasis Rev. 28, 317-326
10. Nicholson, J. K., and Lindon, J. C. (2008) Systems biology: Metabonomics. Nature 455, 1054-1056
11. Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189
12. Holmes, E., Wilson, I. D., and Nicholson, J. K. (2008) Metabolic Phenotyping in Health and Disease. Cell 134, 714-717
13. Spratlin, J. L., Serkova, N. J., and Eckhardt, S. G. (2009) Clinical Applications of Metabolomics in Oncology: A Review. Clin. Cancer Res. 15, 431-440
14. Kind, T., Tolstikov, V., Fiehn, O., and Weiss, R. H. (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal. Biochem. 363, 185-195 (Pubitemid 46428214)
15. Slupsky, C. M., Rankin, K. N., Fu, H., Chang, D., Rowe, B. H., Charles, P. G. P., McGeer, A., Low, D., Long, R., Kunimoto, D., Sawyer, M. B., Fedorak, R. N., Adamko, D. J., Saude, E. J., Shah, S. L., and Marrie, T. J. (2009) Pneumococcal Pneumonia: Potential for Diagnosis through a Urinary Metabolic Profile. J. Proteome Res. 8, 5550-5558
16. Claudino, W. M., Quattrone, A., Biganzoli, L., Pestrin, M., Bertini, I., and Di Leo, A. (2007) Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications. J. Clin. Oncol. 25, 2840-2846 (Pubitemid 47123194)
17. Issaq, H. J., Nativ, O., Waybright, T., Luke, B., Veenstra, T. D., Issaq, E. J., Kravstov, A., and Mullerad, M. (2008) Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry. J. Urol. 179, 2422-2426
18. Cubbon, S., Bradbury, T., Wilson, J., and Thomas-Oates, J. (2007) Hydrophilic Interaction Chromatography for Mass Spectrometric Metabonomic Studies of Urine. Anal. Chem. 79, 8911-8918 (Pubitemid 350231697)
19. Wang, Y., Lehmann, R., Lu, X., Zhao, X., and Xu, G. (2008) Novel, fully automatic hydrophilic interaction/reversed-phase column-switching high-performance liquid chromatographic system for the complementary analysis of polar and apolar compounds in complex samples. J. Chromatogr. A 1204, 28-34
20. Qin, F., Zhao, Y. Y., Sawyer, M. B., and Li, X. F. (2008) Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry Determination of Estrogen Conjugates in Human Urine. Anal. Chem. 80, 3404-3411 (Pubitemid 351620727)
21. Cubbon, S., Antonio, C., Wilson, J., and Thomas-Oates, J. (2010) Metabolomic Applications of HILIC-LC-MS. Mass Spectrom. Rev. 29, 671-684
22. Gika, H. G., Theodoridis, G. A., and Wilson, I. D. (2008) Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. J. Sep. Sci. 31, 1598-1608 (Pubitemid 351890787)
23. Mohamed, R., Varesio, E., Ivosev, G., Burton, L., Bonner, R., and Hopfgartner, G. (2009) Comprehensive Analytical Strategy for Biomarker Identification based on Liquid Chromatography Coupled to Mass Spectrometry and New Candidate Confirmation Tools. Anal. Chem. 81, 7677-7694
24. Epstein, J. I., Amin, M. B., Reuter, V. R., Mostofi, F. K., and Committee, T. B. C. C. (1998) The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder. Am. J. Surg. Pathol. 22, 1435-1448 (Pubitemid 28550639)
25. Chen, J., Wang, W., Lv, S., Yin, P., Zhao, X., Lu, X., Zhang, F., and Xu, G. (2009) Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal. Chim. Acta 650, 3-9
26. Fukui, Y., Kato, M., Inoue, Y., Matsubara, A., and Itoh, K. (2009) A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis. J. Chromatogr. 877, 3806-3812
27. Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., and Jia, W. (2009) Serum Metabolite Profiling of Human Colorectal Cancer Using GC-OFMS and UPLC-TOFMS. J. Proteome Res. 8, 4844-4850
28. Wiklund, S., Nilsson, D., Eriksson, L., Sjöström, M., Wold, S., and Faber, K. (2007) A randomization test for PLS component selection. J. Chemom. 21, 427-439
29. (2005) User's Guide to SIMCA-P, SIMCA-P+ version 11.5
30. Wiklund, S., Johansson, E., Sjöstrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., and Trygg, J. (2008) Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models. Anal. Chem. 80, 115-122 (Pubitemid 351448411)
31. Yin, P., Wan, D., Zhao, C., Chen, J., Zhao, X., Wang, W., Lu, X., Yang, S., Gu, J., and Xu, G. (2009) A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol. Biosyst. 5, 868-876
32. Hilario, M., Kalousis, A., Prados, J., and Binz, P. A. (2004) Data mining for mass-spectra based diagnosis and biomarker discovery. Drug Discov. Today 2, 214-222 (Pubitemid 39349128)
33. Poynard, T., Halfon, P., Castera, L., Munteanu, M., Imbert-Bismut, F., Ratziu, V., Benhamou, Y., Bourliere, M., and de Ledinghen, V. (2007) Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages. Clin. Chem. 53, 1615-1622 (Pubitemid 47340057)
34. Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., and Wright, G. L., Jr. (2002) Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men. Cancer Res. 62, 3609-3614 (Pubitemid 34728833)
35. Keun, H. C., Sidhu, J., Pchejetski, D., Lewis, J. S., Marconell, H., Patterson, M., Bloom, S. R., Amber, V., Coombes, R. C., and Stebbing, J. (2009) Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy. Clin. Cancer Res. 15, 6716-6723
36. Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., Qian, F., Keitz, B., Intengan, M., Lele, S., and Alderfer, J. L. (2005) Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int. J. Cancer 113, 782-788 (Pubitemid 40101260)
37. Evan, G. I., and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348 (Pubitemid 32467043)
38. Ludwig, J. A., and Weinstein, J. N. (2005) Biomarkers in Cancer Staging, Prognosis and Treatment Selection. Nat. Rev. Cancer 5, 845-856 (Pubitemid 41746029)
39. Theodorescu, D., Wittke, S., Ross, M. M., Walden, M., Conaway, M., Just, I., Mischak, H., and Frierson, H. F. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 7, 230-240 (Pubitemid 43286453)
40. Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Lapin, J., Portenoy, R. K., and Esteban-Cruciani, N. (2009) L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study. J. Pain Symptom Manage. 37, 622-631
41. McClinton, S., Moffat, L. E., Horrobin, D. F., and Manku, M. S. (1991) Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br. J. Cancer 63, 314-316